Novadaq Technologies (NVDQ) Stock Soars 95% on Stryker Acquisition Deal

Novadaq Technologies Inc has $17 highest and $11 lowest target. Stifel Nicolaus reiterated a "buy" rating and issued a $10.00 price target on shares of Novadaq Technologies in a research report on Friday, June 2nd.

In a statement this morning, Kalamazoo-based Stryker (NYSE: SYK) said it had reached a definitive agreement to acquire all the issued and outstanding shares in Mississauga-based NOVADAQ Technologies Inc. The rating was initiated by JMP Securities with "Mkt Outperform" on Wednesday, January 6. The research group, a service of Accern, ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. (NASDAQ:NVDQ) earned "Market Perform" rating by William Blair on Wednesday, January 11.

ILLEGAL ACTIVITY NOTICE: "Novadaq Technologies Inc (NVDQ) Earns Buy Rating from Canaccord Genuity" was originally reported by Stock Observer and is the property of of Stock Observer. (NASDAQ:NVDQ) rating on Wednesday, January 11. Stock has got OUTPERFORM rating from 5 of Thomson Reuters analysts, 3 given HOLD rating to the stock and 1 given UNDERPERFORM rating. (NASDAQ:NVDQ) rating on Thursday, October 29. FMR LLC now owns 3,107,271 shares of the medical research company's stock valued at $24,206,000 after buying an additional 726,288 shares during the last quarter. Northern Trust accumulated 2.74 million shares or 0.01% of the stock. With 5.35 million avg volume, 4 days are for US Bancorp (NYSE:USB)'s short sellers to cover USB's short positions. About 1.29M shares traded. Epazz Inc (OTCMKTS:EPAZ) has 0.00% since June 19, 2016 and is. It has outperformed by 6.37% the S&P500. The day's total volume of 22065682 this morning is in contrast from the three-month daily average of 254.69K.

NOVADAQ, SPY, PINPOINT, LUNA and the illumination square design are registered trademarks of NOVADAQ Technologies, Inc. It has underperformed by 41.60% the S&P500. Craig Hallum downgraded Novadaq Technologies Inc. (NASDAQ:NVDQ). Here's a quick look at what's moving shares of SNAP, BA, and NDVQ. Analysts predict that Novadaq Technologies will post ($0.80) EPS for the current fiscal year. After $-0.24 actual EPS reported by Novadaq Technologies Inc. for the previous quarter, Wall Street now forecasts -12.50% EPS growth. The firm's market capitalization is $894.77 million. Its products are designed for use by surgeons in the operating room and other clinical settings where open, minimally invasive or interventional surgical procedures are performed. There is a large variety of Financial Ratios that can be considered while making an investment decision but here in the case of Novadaq Technologies Inc. The company has market cap of $88.43 billion.

FCF is an indicator of a firm's financial performance, measured as operating cash flow minus capital expenditures.

With Novadaq's stock currently trading within a few pennies of its buyout price, it is probably a good idea for shareholders to sell now and put that money to work in other stocks that hold long-term upside potential.



Other news